Reumofan Plus Recalled due to Undeclared Ingredients [Update]
[UPDATE] The FDA informed that Reumofan Tablets, Lot number 99515 with expiration date 09/16, are recalled by Reumofan Plus USA, LLC and Reumofan USA, LLC because they contain undeclared ingredients methocarbamol, dexamethasone, and diclofenac. The product’s packaging did not reveal the presence of the above active pharmaceutical ingredients making it an unapproved drug. So far [...]
Read more
Recent Comments